Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,073 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individuals.
Machmach K, Abad-Molina C, Romero-Sánchez MC, Dominguez-Molina B, Moyano M, Rodriguez MM, Rafii-El-Idrissi Benhnia M, Jimenez-Mejias ME, Vidal F, Muñoz-Fernández MA, Genebat M, Viciana P, González-Escribano MF, Leal M, Ruiz-Mateos E. Machmach K, et al. Among authors: vidal f. Clin Microbiol Infect. 2015 Mar;21(3):289.e1-4. doi: 10.1016/j.cmi.2014.10.012. Epub 2014 Oct 29. Clin Microbiol Infect. 2015. PMID: 25658540 Free article.
HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
Dominguez-Molina B, Tarancon-Diez L, Hua S, Abad-Molina C, Rodriguez-Gallego E, Machmach K, Vidal F, Tural C, Moreno S, Goñi JM, Ramírez de Arellano E, Del Val M, Gonzalez-Escribano MF, Del Romero J, Rodriguez C, Capa L, Viciana P, Alcamí J, Yu XG, Walker BD, Leal M, Lichterfeld M, Ruiz-Mateos E; ECRIS integrated in the Spanish AIDS Research Network. Dominguez-Molina B, et al. Among authors: vidal f. Clin Infect Dis. 2017 Mar 1;64(5):621-628. doi: 10.1093/cid/ciw833. Epub 2016 Dec 16. Clin Infect Dis. 2017. PMID: 27986689 Free PMC article.
A Lower Baseline CD4/CD8 T-Cell Ratio Is Independently Associated with Immunodiscordant Response to Antiretroviral Therapy in HIV-Infected Subjects.
Rosado-Sánchez I, Herrero-Fernández I, Álvarez-Ríos AI, Genebat M, Abad-Carrillo MA, Ruiz-Mateos E, Pulido F, González-García J, Montero M, Bernal-Morell E, Vidal F, Leal M, Pacheco YM. Rosado-Sánchez I, et al. Among authors: vidal f. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00605-17. doi: 10.1128/AAC.00605-17. Print 2017 Aug. Antimicrob Agents Chemother. 2017. PMID: 28559274 Free PMC article.
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
HIV-CAUSAL Collaboration; Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA. HIV-CAUSAL Collaboration, et al. Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6. Clin Infect Dis. 2015. PMID: 25567330 Free PMC article.
HIV/antiretroviral therapy-related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma.
Peraire J, López-Dupla M, Alba V, Beltrán-Debón R, Martinez E, Domingo P, Asensi V, Leal M, Viladés C, Inza MI, Escoté X, Arnedo M, Mateo G, Valle-Garay E, Ferrando-Martinez S, Veloso S, Vendrell J, Gatell JM, Vidal F; HIV-1 Lipodystrophy Study Group. Peraire J, et al. Among authors: vidal f. Clin Microbiol Infect. 2015 Jul;21(7):711.e1-8. doi: 10.1016/j.cmi.2015.04.002. Epub 2015 Apr 14. Clin Microbiol Infect. 2015. PMID: 25882366 Free article.
Correlation of the virological response to short-term maraviroc monotherapy with standard and deep-sequencing-based genotypic tropism prediction methods.
Gonzalez-Serna A, McGovern RA, Harrigan PR, Vidal F, Poon AF, Ferrando-Martinez S, Abad MA, Genebat M, Leal M, Ruiz-Mateos E. Gonzalez-Serna A, et al. Among authors: vidal f. Antimicrob Agents Chemother. 2012 Mar;56(3):1202-7. doi: 10.1128/AAC.05857-11. Epub 2011 Dec 5. Antimicrob Agents Chemother. 2012. PMID: 22143533 Free PMC article.
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status.
Moreno S, Jarrin I, Iribarren JA, Perez-Elías MJ, Viciana P, Parra-Ruiz J, Gomez-Sirvent JL, Lopez-Aldeguer J, Gutierrez F, Blanco JR, Vidal F, Leal M, Rodríguez Arenas MA, Del Amo J; CoRIS-MD. Moreno S, et al. Among authors: vidal f. Int J Tuberc Lung Dis. 2008 Dec;12(12):1393-400. Int J Tuberc Lung Dis. 2008. PMID: 19017448
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patients.
Suarez-Lozano I, Viciana P, Lacalle JR, Teira R, Lozano F, Lopez-Aldeguer J, Pedrol E, Domingo P, Cosin J, Roca B, Geijo P, Fuente B, Vergara A, Ribera E, Galindo MJ, Zapata A, Sanchez T, Vidal F, Munoz-Sanz A, Munoz-Sanchez J, Garrido M. Suarez-Lozano I, et al. Among authors: vidal f. HIV Med. 2009 Oct;10(9):573-9. doi: 10.1111/j.1468-1293.2009.00731.x. HIV Med. 2009. PMID: 19785666 Free article.
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J, Pérez-Hoyos S, Jarrín I, Phillips A, Lodi S, van Sighem A, de Wolf W, Sabin C, Bansi L, Justice A, Goulet J, Miró JM, Ferrer E, Meyer L, Seng R, Toulomi G, Gargalianos P, Costagliola D, Abgrall S, Hernán MA; HIV-CAUSAL Collaboration. del Amo J, et al. Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28. Clin Infect Dis. 2012. PMID: 22460971 Free PMC article.
1,073 results